Literature DB >> 12033342

Temporal patterns of atrial arrhythmia recurrences in patients with implantable defibrillators: implications for assessing antiarrhythmic therapies.

Lina A Shehadeh1, Larry S Liebovitch, Mark A Wood.   

Abstract

INTRODUCTION: The statistical measures commonly used to assess therapies for recurrent atrial arrhythmias (such as time to first recurrence) often assume a uniformly random pattern of arrhythmic events over time. However, the true temporal pattern of atrial arrhythmia recurrences is unknown. The aim of this study was to use linear and nonlinear analyses to characterize the temporal pattern of atrial arrhythmia recurrences in patients with implantable cardioverter defibrillators. METHODS AND
RESULTS: The time and date of atrial tachyarrhythmias recorded in 65 patients with combined atrial and ventricular defibrillators were used to construct a probability density function (PDF) and a model of a Poisson distribution of arrhythmic events for each patient. Average patient age was 66 +/- 10 years and follow-up was 7.8 +/- 4.8 months. A total of 10,759 episodes of atrial tachyarrhythmias were analyzed (range 43 to 618 episodes per patient). The PDF fit a power law distribution for all 65 patients, with an average r2 = 0.89 +/- 0.08. The PDF distribution differed significantly from the model Poisson distribution in 47 of 65 patients (P = 0.0002). Differences from the Poisson distribution were noted for patients both taking (30/43 patients; P < or = 0.015) and not taking (17/22 patients; P < or = 0.017) antiarrhythmic drugs. Median time between atrial arrhythmia detections for all 65 patients was 10.8 minutes.
CONCLUSION: In implantable cardioverter defibrillator patients, the temporal pattern of frequent recurrences of atrial tachyarrhythmias usually is characterized by a power law distribution. The unique statistical properties of this type of distribution should be considered in designing outcome measures for treatment of atrial tachyarrhythmias.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12033342     DOI: 10.1046/j.1540-8167.2002.00303.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  5 in total

1.  A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers.

Authors:  Michael D Ezekowitz; Kenneth A Ellenbogen; John P DiMarco; Karoly Kaszala; Alexander Boddy; Gregory P Geba; Gregory Geba P; Andrew Koren
Journal:  J Interv Card Electrophysiol       Date:  2015-02-01       Impact factor: 1.900

2.  Recurrent event survival analysis predicts future risk of hospitalization in patients with paroxysmal and persistent atrial fibrillation.

Authors:  Jakob Schroder; Olivier Bouaziz; Bue Ross Agner; Torben Martinussen; Per Lav Madsen; Dana Li; Ulrik Dixen
Journal:  PLoS One       Date:  2019-06-07       Impact factor: 3.240

Review 3.  The role of pacing in rhythm control and management of atrial fibrillation.

Authors:  John Silberbauer; Neil Sulke
Journal:  J Interv Card Electrophysiol       Date:  2007-05-02       Impact factor: 1.759

4.  A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology.

Authors:  Anita Arya; John Silberbauer; Sam L Teichman; Peter Milner; Neil Sulke; A John Camm
Journal:  Europace       Date:  2009-01-26       Impact factor: 5.214

5.  A Stochastic Individual-Based Model of the Progression of Atrial Fibrillation in Individuals and Populations.

Authors:  Eugene T Y Chang; Yen Ting Lin; Tobias Galla; Richard H Clayton; Julie Eatock
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.